Dabigatran Etexilate Accord
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Dabigatran Etexilate Accord |
|---|---|
| Active Substance | dabigatraneteksilatmesilat |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| ATC Code | B01AE07 |
| Medicinal product marketed in the Croatia | Da |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
| Educational materials for healthcare professionals |
Vodič za propisivače lijeka pVTE, verzija 6 Vodič za propisivače lijeka pSPAF, DVT, PE, verzija 6 Vodič za propisivače lijeka pVTE pedijatrijska populacija, verzija 2 |
| Educational materials for patients / caregivers |
Kartica s upozorenjima za bolesnika |
